Novavax COVID-19 vaccine production set back due to supply shortages

Novavax Inc has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the third quarter due to supply shortages, dealing another blow to the federal government’s rollout plans.

Australia has an agreement for 51 million doses of Novavax originally slated for “mid-2021”, at which point executives had said full-scale vaccine production could…